$MYOK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MyoKardia, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in MyoKardia, Inc.. Get notifications about new insider transactions in MyoKardia, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Buy | M | 11.95 | 364 | 4,350 | 18,793 | 18.4 K to 18.8 K (+1.98 %) |
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Buy | M | 11.95 | 2,500 | 29,875 | 18,429 | 15.9 K to 18.4 K (+15.69 %) |
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Buy | M | 11.95 | 364 | 4,350 | 15,929 | 15.6 K to 15.9 K (+2.34 %) |
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Buy | M | 11.95 | 364 | 4,350 | 15,565 | 15.2 K to 15.6 K (+2.39 %) |
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Buy | M | 11.95 | 363 | 4,338 | 15,201 | 14.8 K to 15.2 K (+2.45 %) |
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Buy | M | 11.95 | 364 | 4,350 | 14,838 | 14.5 K to 14.8 K (+2.51 %) |
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Buy | M | 11.95 | 364 | 4,350 | 14,474 | 14.1 K to 14.5 K (+2.58 %) |
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Buy | M | 11.95 | 4,500 | 53,775 | 14,110 | 9.6 K to 14.1 K (+46.83 %) |
Oct 29 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Buy | M | 11.95 | 5,457 | 65,211 | 9,610 | 4.2 K to 9.6 K (+131.40 %) |
Oct 04 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 55.00 | 1,000 | 55,000 | 96,470 | 97.5 K to 96.5 K (-1.03 %) |
Oct 04 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 53.10 | 758 | 40,248 | 97,470 | 98.2 K to 97.5 K (-0.77 %) |
Oct 04 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 52.29 | 2,542 | 132,933 | 98,228 | 100.8 K to 98.2 K (-2.52 %) |
Oct 04 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 51.33 | 700 | 35,930 | 100,770 | 101.5 K to 100.8 K (-0.69 %) |
Sep 24 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Option Exercise | M | 11.95 | 12,625 | 150,869 | 115,617 | |
Sep 24 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Sell | S | 61.09 | 4,161 | 254,191 | 4,153 | 8.3 K to 4.2 K (-50.05 %) |
Sep 24 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Sell | S | 59.95 | 800 | 47,960 | 8,314 | 9.1 K to 8.3 K (-8.78 %) |
Sep 24 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Sell | S | 58.97 | 4,161 | 245,389 | 9,114 | 13.3 K to 9.1 K (-31.34 %) |
Sep 24 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Sell | S | 58.33 | 3,929 | 229,184 | 13,275 | 17.2 K to 13.3 K (-22.84 %) |
Sep 24 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Buy | M | 11.95 | 12,625 | 150,869 | 17,204 | 4.6 K to 17.2 K (+275.72 %) |
Sep 24 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Option Exercise | M | 12.25 | 9,700 | 118,825 | 40,150 | |
Sep 24 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Option Exercise | M | 9.08 | 10,000 | 90,800 | 18,748 | |
Sep 24 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Sell | S | 60.09 | 19,700 | 1,183,777 | 66,068 | 85.8 K to 66.1 K (-22.97 %) |
Sep 24 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Buy | M | 12.25 | 9,700 | 118,825 | 85,768 | 76.1 K to 85.8 K (+12.75 %) |
Sep 24 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Buy | M | 9.08 | 10,000 | 90,800 | 76,068 | 66.1 K to 76.1 K (+15.14 %) |
Sep 20 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Option Exercise | M | 11.95 | 5,435 | 64,948 | 128,242 | |
Sep 20 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Sell | S | 57.08 | 5,435 | 310,254 | 4,579 | 10 K to 4.6 K (-54.27 %) |
Sep 20 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Buy | M | 11.95 | 5,435 | 64,948 | 10,014 | 4.6 K to 10 K (+118.69 %) |
Sep 12 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 55.00 | 1,000 | 55,000 | 101,470 | 102.5 K to 101.5 K (-0.98 %) |
Sep 05 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 54.09 | 1,100 | 59,500 | 102,470 | 103.6 K to 102.5 K (-1.06 %) |
Sep 05 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 52.75 | 1,000 | 52,750 | 103,570 | 104.6 K to 103.6 K (-0.96 %) |
Sep 05 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 50.70 | 1,900 | 96,335 | 104,570 | 106.5 K to 104.6 K (-1.78 %) |
Aug 12 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Option Exercise | M | 11.95 | 4,565 | 54,552 | 133,677 | |
Aug 12 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Sell | S | 57.00 | 4,565 | 260,219 | 4,579 | 9.1 K to 4.6 K (-49.92 %) |
Aug 12 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Buy | M | 11.95 | 4,565 | 54,552 | 9,144 | 4.6 K to 9.1 K (+99.69 %) |
Aug 09 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 55.09 | 1,000 | 55,090 | 106,470 | 107.5 K to 106.5 K (-0.93 %) |
Aug 05 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 53.82 | 200 | 10,764 | 107,470 | 107.7 K to 107.5 K (-0.19 %) |
Aug 05 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 53.20 | 3,800 | 202,171 | 107,670 | 111.5 K to 107.7 K (-3.41 %) |
Jul 23 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 55.00 | 1,000 | 55,000 | 111,470 | 112.5 K to 111.5 K (-0.89 %) |
Jul 08 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 50.10 | 2,450 | 122,752 | 112,470 | 114.9 K to 112.5 K (-2.13 %) |
Jul 08 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 49.13 | 1,550 | 76,151 | 114,920 | 116.5 K to 114.9 K (-1.33 %) |
Jul 08 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Gift | G | 0.00 | 39,000 | 0 | 49,473 | 88.5 K to 49.5 K (-44.08 %) |
Jul 08 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Gift | G | 0.00 | 39,000 | 0 | 116,470 | 77.5 K to 116.5 K (+50.34 %) |
Jun 17 2019 | MYOK | MyoKardia Inc | PERRY MARK L | Director | Option Exercise | A | 0.00 | 2,300 | 0 | 2,300 | |
Jun 17 2019 | MYOK | MyoKardia Inc | PERRY MARK L | Director | Option Exercise | A | 47.17 | 6,600 | 311,322 | 6,600 | |
Jun 17 2019 | MYOK | MyoKardia Inc | YARNO WENDY L | Director | Option Exercise | A | 0.00 | 2,300 | 0 | 2,300 | |
Jun 17 2019 | MYOK | MyoKardia Inc | YARNO WENDY L | Director | Option Exercise | A | 47.17 | 6,600 | 311,322 | 6,600 | |
Jun 17 2019 | MYOK | MyoKardia Inc | CRANSTON MARY B | Director | Option Exercise | A | 0.00 | 2,300 | 0 | 2,300 | |
Jun 17 2019 | MYOK | MyoKardia Inc | CRANSTON MARY B | Director | Option Exercise | A | 47.17 | 6,600 | 311,322 | 6,600 | |
Jun 17 2019 | MYOK | MyoKardia Inc | Meeker David P | Director | Option Exercise | A | 0.00 | 2,300 | 0 | 2,300 | |
Jun 17 2019 | MYOK | MyoKardia Inc | Meeker David P | Director | Option Exercise | A | 47.17 | 6,600 | 311,322 | 6,600 | |
Jun 17 2019 | MYOK | MyoKardia Inc | AGARWAL SUNIL | Director | Option Exercise | A | 0.00 | 2,300 | 0 | 2,300 | |
Jun 17 2019 | MYOK | MyoKardia Inc | AGARWAL SUNIL | Director | Option Exercise | A | 47.17 | 6,600 | 311,322 | 6,600 | |
Jun 17 2019 | MYOK | MyoKardia Inc | Popovits Kimberly J | Director | Option Exercise | A | 0.00 | 2,300 | 0 | 2,300 | |
Jun 17 2019 | MYOK | MyoKardia Inc | Popovits Kimberly J | Director | Option Exercise | A | 47.17 | 6,600 | 311,322 | 6,600 | |
Jun 03 2019 | MYOK | MyoKardia Inc | Lee June | EVP, Chief Developm ... | Grant | A | 40.78 | 401 | 16,354 | 4,579 | 4.2 K to 4.6 K (+9.60 %) |
Jun 03 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Grant | A | 40.78 | 313 | 12,765 | 66,068 | 65.8 K to 66.1 K (+0.48 %) |
Jun 03 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Grant | A | 40.78 | 503 | 20,514 | 77,470 | 77 K to 77.5 K (+0.65 %) |
Apr 09 2019 | MYOK | MyoKardia Inc | Harris Taylor C. | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,750 | 0 | 11,250 | |
Apr 09 2019 | MYOK | MyoKardia Inc | Harris Taylor C. | Chief Financial Off ... | Sell | S | 53.30 | 1,324 | 70,569 | 2,426 | 3.8 K to 2.4 K (-35.31 %) |
Apr 09 2019 | MYOK | MyoKardia Inc | Harris Taylor C. | Chief Financial Off ... | Buy | M | 0.00 | 3,750 | 0 | 3,750 | 0 to 3.8 K |
Mar 18 2019 | MYOK | MyoKardia Inc | Lee June | See Remarks | Option Exercise | M | 11.95 | 1,758 | 21,008 | 138,242 | |
Mar 18 2019 | MYOK | MyoKardia Inc | Lee June | See Remarks | Buy | M | 11.95 | 1,758 | 21,008 | 4,178 | 2.4 K to 4.2 K (+72.64 %) |
Feb 15 2019 | MYOK | MyoKardia Inc | Sanofi | 10% Owner | Sell | S | 37.66 | 4,168,899 | 157,000,736 | 0 | 4.2 M to 0 (-100.00 %) |
Feb 12 2019 | MYOK | MyoKardia Inc | LADD CYNTHIA J | General Counsel | Option Exercise | A | 0.00 | 18,800 | 0 | 18,800 | |
Feb 12 2019 | MYOK | MyoKardia Inc | LADD CYNTHIA J | General Counsel | Option Exercise | A | 40.11 | 55,100 | 2,210,061 | 55,100 | |
Feb 12 2019 | MYOK | MyoKardia Inc | Semigran Marc | Chief Medical Offic ... | Option Exercise | A | 0.00 | 8,500 | 0 | 8,500 | |
Feb 12 2019 | MYOK | MyoKardia Inc | Semigran Marc | Chief Medical Offic ... | Option Exercise | A | 40.11 | 24,900 | 998,739 | 24,900 | |
Feb 12 2019 | MYOK | MyoKardia Inc | Lambing Joseph | See Remarks | Option Exercise | A | 0.00 | 8,500 | 0 | 8,500 | |
Feb 12 2019 | MYOK | MyoKardia Inc | Lambing Joseph | See Remarks | Option Exercise | A | 40.11 | 24,900 | 998,739 | 24,900 | |
Feb 12 2019 | MYOK | MyoKardia Inc | McDowell Robert Scott | Chief Scientific Of ... | Option Exercise | A | 0.00 | 19,800 | 0 | 19,800 | |
Feb 12 2019 | MYOK | MyoKardia Inc | McDowell Robert Scott | Chief Scientific Of ... | Option Exercise | A | 40.11 | 57,400 | 2,302,314 | 57,400 | |
Feb 12 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | A | 0.00 | 81,200 | 0 | 81,200 | |
Feb 12 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | A | 40.11 | 236,500 | 9,486,015 | 236,500 | |
Feb 12 2019 | MYOK | MyoKardia Inc | Harris Taylor C. | Chief Financial Off ... | Option Exercise | A | 0.00 | 17,000 | 0 | 17,000 | |
Feb 12 2019 | MYOK | MyoKardia Inc | Harris Taylor C. | Chief Financial Off ... | Option Exercise | A | 40.11 | 49,400 | 1,981,434 | 49,400 | |
Feb 12 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Option Exercise | A | 0.00 | 19,800 | 0 | 19,800 | |
Feb 12 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Option Exercise | A | 40.11 | 57,400 | 2,302,314 | 57,400 | |
Feb 05 2019 | MYOK | MyoKardia Inc | Fairey William | See Remarks | Option Exercise | A | 0.00 | 32,500 | 0 | 32,500 | |
Feb 05 2019 | MYOK | MyoKardia Inc | Fairey William | See Remarks | Option Exercise | A | 40.99 | 69,500 | 2,848,805 | 69,500 | |
Jan 11 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 44.11 | 2,770 | 122,197 | 76,967 | 79.7 K to 77 K (-3.47 %) |
Jan 09 2019 | MYOK | MyoKardia Inc | Lee June | See Remarks | Payment of Exercise | F | 44.06 | 1,100 | 48,467 | 2,420 | 3.5 K to 2.4 K (-31.25 %) |
Jan 09 2019 | MYOK | MyoKardia Inc | Semigran Marc | Chief Medical Offic ... | Payment of Exercise | F | 44.26 | 517 | 22,880 | 1,110 | 1.6 K to 1.1 K (-31.78 %) |
Jan 09 2019 | MYOK | MyoKardia Inc | Lee June | See Remarks | Payment of Exercise | F | 44.06 | 1,100 | 48,467 | 2,420 | 3.5 K to 2.4 K (-31.25 %) |
Jan 09 2019 | MYOK | MyoKardia Inc | Semigran Marc | Chief Medical Offic ... | Payment of Exercise | F | 44.26 | 517 | 22,880 | 1,110 | 1.6 K to 1.1 K (-31.78 %) |
Jan 09 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Payment of Exercise | F | 42.98 | 570 | 24,496 | 60,755 | 61.3 K to 60.8 K (-0.93 %) |
Jan 09 2019 | MYOK | MyoKardia Inc | Lambing Joseph | See Remarks | Payment of Exercise | F | 43.99 | 351 | 15,439 | 94,740 | 95.1 K to 94.7 K (-0.37 %) |
Jan 09 2019 | MYOK | MyoKardia Inc | McDowell Robert Scott | Chief Scientific Of ... | Payment of Exercise | F | 44.15 | 767 | 33,863 | 1,158 | 1.9 K to 1.2 K (-39.84 %) |
Jan 09 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Payment of Exercise | F | 42.98 | 570 | 24,496 | 60,755 | 61.3 K to 60.8 K (-0.93 %) |
Jan 09 2019 | MYOK | MyoKardia Inc | Lambing Joseph | See Remarks | Payment of Exercise | F | 43.99 | 351 | 15,439 | 94,740 | 95.1 K to 94.7 K (-0.37 %) |
Jan 09 2019 | MYOK | MyoKardia Inc | McDowell Robert Scott | Chief Scientific Of ... | Payment of Exercise | F | 44.15 | 767 | 33,863 | 1,158 | 1.9 K to 1.2 K (-39.84 %) |
Jan 08 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | P | 39.87 | 1,600 | 63,796 | 88,473 | 86.9 K to 88.5 K (+1.84 %) |
Jan 08 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | P | 39.84 | 900 | 35,852 | 86,873 | 86 K to 86.9 K (+1.05 %) |
Jan 03 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 0.00 | 7,650 | 0 | 22,950 | |
Jan 03 2019 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 0.00 | 7,650 | 0 | 79,737 | 72.1 K to 79.7 K (+10.61 %) |
Jan 03 2019 | MYOK | MyoKardia Inc | Semigran Marc | Chief Medical Offic ... | Option Exercise | M | 0.00 | 1,325 | 0 | 3,975 | |
Jan 03 2019 | MYOK | MyoKardia Inc | Semigran Marc | Chief Medical Offic ... | Buy | M | 0.00 | 1,325 | 0 | 1,627 | 302 to 1.6 K (+438.74 %) |
Jan 03 2019 | MYOK | MyoKardia Inc | Lambing Joseph | See Remarks | Option Exercise | M | 0.00 | 875 | 0 | 2,625 | |
Jan 03 2019 | MYOK | MyoKardia Inc | Lambing Joseph | See Remarks | Buy | M | 0.00 | 875 | 0 | 95,091 | 94.2 K to 95.1 K (+0.93 %) |
Jan 03 2019 | MYOK | MyoKardia Inc | Lee June | See Remarks | Option Exercise | M | 0.00 | 2,750 | 0 | 8,250 | |
Jan 03 2019 | MYOK | MyoKardia Inc | Lee June | See Remarks | Buy | M | 0.00 | 2,750 | 0 | 3,520 | 770 to 3.5 K (+357.14 %) |
Jan 03 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Option Exercise | M | 0.00 | 1,425 | 0 | 4,275 | |
Jan 03 2019 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Buy | M | 0.00 | 1,425 | 0 | 61,325 | 59.9 K to 61.3 K (+2.38 %) |
Jan 03 2019 | MYOK | MyoKardia Inc | McDowell Robert Scott | Chief Scientific Of ... | Option Exercise | M | 0.00 | 1,925 | 0 | 5,775 | |
Jan 03 2019 | MYOK | MyoKardia Inc | McDowell Robert Scott | Chief Scientific Of ... | Buy | M | 0.00 | 1,925 | 0 | 1,925 | 0 to 1.9 K |
Dec 20 2018 | MYOK | MyoKardia Inc | Lambing Joseph | See Remarks | Grant | A | 42.16 | 302 | 12,732 | 94,216 | 93.9 K to 94.2 K (+0.32 %) |
Dec 20 2018 | MYOK | MyoKardia Inc | Semigran Marc | Chief Medical Offic ... | Grant | A | 42.16 | 302 | 12,732 | 302 | 0 to 302 |
Dec 13 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 55.68 | 3,000 | 167,045 | 72,087 | 75.1 K to 72.1 K (-4.00 %) |
Dec 13 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 55.68 | 3,000 | 167,045 | 72,087 | 75.1 K to 72.1 K (-4.00 %) |
Dec 06 2018 | MYOK | MyoKardia Inc | Lee June | See Remarks | Option Exercise | M | 11.95 | 5,000 | 59,750 | 140,000 | |
Dec 06 2018 | MYOK | MyoKardia Inc | Lee June | See Remarks | Buy | S | 63.76 | 200 | 12,752 | 770 | 570 to 770 (+35.09 %) |
Dec 06 2018 | MYOK | MyoKardia Inc | Lee June | See Remarks | Buy | S | 62.26 | 800 | 49,807 | 970 | 170 to 970 (+470.59 %) |
Dec 06 2018 | MYOK | MyoKardia Inc | Lee June | See Remarks | Buy | S | 61.07 | 1,200 | 73,285 | 1,770 | 570 to 1.8 K (+210.53 %) |
Dec 06 2018 | MYOK | MyoKardia Inc | Lee June | See Remarks | Buy | S | 60.08 | 2,800 | 168,216 | 2,970 | 170 to 3 K (+1,647.06 %) |
Dec 06 2018 | MYOK | MyoKardia Inc | Lee June | See Remarks | Buy | M | 11.95 | 5,000 | 59,750 | 5,770 | 770 to 5.8 K (+649.35 %) |
Dec 06 2018 | MYOK | MyoKardia Inc | Lee June | See Remarks | Grant | A | 42.16 | 344 | 14,503 | 770 | 426 to 770 (+80.75 %) |
Nov 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 3,000 | 4,520 | 105,254 | |
Nov 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 57.49 | 200 | 11,498 | 75,087 | 75.3 K to 75.1 K (-0.27 %) |
Nov 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 56.78 | 2,300 | 130,588 | 75,287 | 77.6 K to 75.3 K (-2.96 %) |
Nov 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 55.26 | 500 | 27,630 | 77,587 | 78.1 K to 77.6 K (-0.64 %) |
Nov 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 3,000 | 4,520 | 78,087 | 75.1 K to 78.1 K (+4.00 %) |
Nov 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Grant | A | 42.16 | 138 | 5,818 | 75,087 | 74.9 K to 75.1 K (+0.18 %) |
Nov 06 2018 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Sell | S | 55.45 | 978 | 54,230 | 59,900 | 60.9 K to 59.9 K (-1.61 %) |
Nov 06 2018 | MYOK | MyoKardia Inc | Bauer Jake | Chief Business Offi ... | Grant | A | 42.16 | 272 | 11,468 | 60,878 | 60.6 K to 60.9 K (+0.45 %) |
Oct 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 3,000 | 4,520 | 108,254 | |
Oct 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 59.44 | 1,100 | 65,382 | 74,949 | 76 K to 74.9 K (-1.45 %) |
Oct 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 58.15 | 700 | 40,708 | 76,049 | 76.7 K to 76 K (-0.91 %) |
Oct 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 57.07 | 1,200 | 68,488 | 76,749 | 77.9 K to 76.7 K (-1.54 %) |
Oct 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 3,000 | 4,520 | 77,949 | 74.9 K to 77.9 K (+4.00 %) |
Oct 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 3,000 | 4,520 | 108,254 | |
Oct 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 59.44 | 1,100 | 65,382 | 74,949 | 76 K to 74.9 K (-1.45 %) |
Oct 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 58.15 | 700 | 40,708 | 76,049 | 76.7 K to 76 K (-0.91 %) |
Oct 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 57.07 | 1,200 | 68,488 | 76,749 | 77.9 K to 76.7 K (-1.54 %) |
Oct 05 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 3,000 | 4,520 | 77,949 | 74.9 K to 77.9 K (+4.00 %) |
Sep 24 2018 | MYOK | MyoKardia Inc | Lee June | See Remarks | Option Exercise | M | 11.95 | 5,000 | 59,750 | 145,000 | |
Sep 24 2018 | MYOK | MyoKardia Inc | Lee June | See Remarks | Sell | S | 63.84 | 908 | 57,963 | 426 | 1.3 K to 426 (-68.07 %) |
Sep 24 2018 | MYOK | MyoKardia Inc | Lee June | See Remarks | Sell | S | 62.97 | 4,092 | 257,689 | 1,334 | 5.4 K to 1.3 K (-75.41 %) |
Sep 24 2018 | MYOK | MyoKardia Inc | Lee June | See Remarks | Buy | M | 11.95 | 5,000 | 59,750 | 5,426 | 426 to 5.4 K (+1,173.71 %) |
Sep 06 2018 | MYOK | MyoKardia Inc | Semigran Marc | Chief Medical Offic ... | Option Exercise | M | 15.95 | 3,600 | 57,420 | 130,000 | |
Sep 06 2018 | MYOK | MyoKardia Inc | Semigran Marc | Chief Medical Offic ... | Option Exercise | M | 15.95 | 41,400 | 660,330 | 133,600 | |
Sep 06 2018 | MYOK | MyoKardia Inc | Semigran Marc | Chief Medical Offic ... | Sell | S | 60.00 | 3,600 | 216,000 | 0 | 3.6 K to 0 (-100.00 %) |
Sep 06 2018 | MYOK | MyoKardia Inc | Semigran Marc | Chief Medical Offic ... | Buy | M | 15.95 | 3,600 | 57,420 | 3,600 | 0 to 3.6 K |
Sep 06 2018 | MYOK | MyoKardia Inc | Semigran Marc | Chief Medical Offic ... | Sell | S | 59.49 | 41,400 | 2,463,006 | 0 | 41.4 K to 0 (-100.00 %) |
Sep 06 2018 | MYOK | MyoKardia Inc | Semigran Marc | Chief Medical Offic ... | Buy | M | 15.95 | 41,400 | 660,330 | 41,400 | 0 to 41.4 K |
Sep 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 3,000 | 4,520 | 111,254 | |
Sep 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 59.96 | 500 | 29,980 | 74,949 | 75.4 K to 74.9 K (-0.66 %) |
Sep 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 59.21 | 2,500 | 148,024 | 75,449 | 77.9 K to 75.4 K (-3.21 %) |
Sep 06 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Buy | M | 1.51 | 3,000 | 4,520 | 77,949 | 74.9 K to 77.9 K (+4.00 %) |
Aug 08 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Option Exercise | M | 1.51 | 3,000 | 4,520 | 114,254 | |
Aug 08 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 57.65 | 2,200 | 126,830 | 74,949 | 77.1 K to 74.9 K (-2.85 %) |
Aug 08 2018 | MYOK | MyoKardia Inc | GIANAKAKOS ANASTASIOS | President and CEO | Sell | S | 56.98 | 800 | 45,580 | 77,149 | 77.9 K to 77.1 K (-1.03 %) |